Table 1 Demographic and clinico-pathological characteristics of cases
From: MYC amplification in subtypes of breast cancers in African American women
Characteristics | Mean | Range |
|---|---|---|
Age of Diagnosis (Years) | ||
56.36 years | 29–85 years | |
Tumor Size | 58.0 mm | 2.0–120.0 mm |
Frequency | Percentage | |
Breast Cancer Subtypes | ||
HER2 | 8 | 11.4 |
Luminal A | 21 | 30 |
Luminal B | 15 | 21.4 |
Luminal B (Ki-67 ≥ 14%) | 9 | 12.9 |
Luminal B HER2+ | 6 | 8.6 |
Triple Negative | 26 | 37.1 |
ER Status | ||
Positive | 35 | 50 |
Negative | 35 | 50 |
PR Status | ||
Positive | 32 | 45.7 |
Negative | 38 | 54.3 |
HER2 Status | ||
Amplified | 13 | 18.6 |
Not Amplified | 57 | 81.4 |
Stage | ||
I | 15 | 23.4 |
II | 29 | 41.4 |
III | 16 | 22.9 |
IV | 4 | 5.7 |
Grade | ||
Grade I: Well differentiated | 1 | 1.4 |
Grade II: Moderately differentiated | 15 | 21.4 |
Grade III: Poorly differentiated | 52 | 74.3 |